Waters Application Note
Beth Gillece-Castro, Kim van Tran, Jonathan E. Turner, Thomas E. Wheat and Diane M. Diehl, Waters Corp., Milford, Massachusetts, USA.
Glycosylation is a post-translational modification process that can significantly affect the biological properties of therapeutic proteins. The successful analysis of N- and O-linked glycan structures requires the ability to reproducibly resolve complex mixtures of isomeric oligosaccharides. Hydrophilic-interaction liquid chromatography (HILIC) is a powerful technique for separating a wide range of glycan structures. If the glycans have been labelled with a tag such as 2-amino benzamide (2-AB), the fluorescence can be monitored and used for relative quantification. The technique of Ultra Performance Liquid Chromatography (UPLC) is appropriate for such a difficult analytical problem. UPLC is based on the use of columns packed with very small particles and instruments optimized for use with these high resolution columns. The ACQUITY UPLC BEH Glycan column was specifically designed for use with Waters ACQUITY UPLC system. This analytical solution gives improved resolution, sensitivity and speed compared to HPLC techniques.
Figure 1: The N-linked glycans from pooled human IgG include high mannose, neutral and sialylated complex structures. The chromatogram shows 35 minutes of a one hour run.
Figure 1 sample: 15 pmol 2-AB-(human IgG library)*
Figure 2 sample: 15 pmol 2-AB-(bovine fetuin library)*
Column: ACQUITY UPLC BEH glycan 1.7μm, 2.1 × 150 mm
Eluent A: 100 mM ammonium formate, pH 4.5
Eluent B: Acetonitrile
Figure 1 gradient: 75–50% B over 46.5 min
Figure 2 gradient: 75–60% B over 46.5 min
Temperature: 60 °C
*ProZyme, San Leandro, California, USA
The first chromatogram shows the separation of N-linked oligosaccharides released from human IgG and labelled with 2-AB. This sample naturally includes a mixture of high mannose, complex, hybrid and sialylated glycans. Because the mixture contains a wide range of glycan classes, this sample was chosen for use as the QC standard for developing and manufacturing this column. This test ensures reproducible selectivity and resolution.
Figure 2: Analysis of 2-AB (Bovine Fetuin N-linked glycan library). Highlighted(*) are multiple peaks with a single molecular weight corresponding to disialylated biantennary glycans.
The chromatographic separation of all of the major oligosaccharides in the mixture, G0F, G1F, G2F and sialylated G2F is shown. The resolution of the structure G0F (peak 2) from the structure Man5 (peak 3) is particularly important. The two isomers of G1F are also completely resolved and the significance of their relative abundance may now be investigated.
The second chromatogram shows the separation of glycans released from bovine fetuin. These oligosaccharides include differing numbers of branch antennae and differing numbers of charged, acidic sialic acid termini. A challenging pair of isomers that are resolved (*) are triantennary glycans with two sialic acid residues and they elute at 41.4 and 43.1 minutes.
Glycan separation technology columns, when operated with the ACQUITY UPLC instrument and FLR detector provide a highly-resolving, reproducible, rapid method for profiling glycans. The improved analysis provides more certain identification and reliable quantification.
For complete details, visit www.waters.com/31123
© 2009 Waters Corporation. Waters, The Science of What's Possible, UPLC, and ACQUITY UPLC are trademarks of Waters Corporation.
Waters Corporation
34 Maple Street, Milford, Massachusetts 01757, USA
tel. +1 508 478 2000 fax +1 508 482 3605
Website: www.waters.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Katelynn Perrault Uptmor Receives the 2025 LCGC Emerging Leader in Chromatography Award
Published: November 13th 2024 | Updated: November 13th 2024November 13, 2024 – LCGC International magazine has named Katelynn A. Perrault Uptmor, Assistant Professor of Chemistry at the College of William & Mary, the recipient of the 2025 Emerging Leader in Chromatography Award. This accolade, which highlights exceptional achievements by early-career scientists, celebrates Perrault Uptmor’s pioneering work in chromatography, particularly in the fields of forensic science, odor analysis, and complex volatile organic compounds (VOCs) research.